Research by physicians and scientists shows that a test for measuring the length of DNA endcaps, called telomeres, which has a variability rate of 5 percent, can alter treatment decisions for patients with certain types of bone marrow failure.
from Top Health News – ScienceDaily http://bit.ly/2osKzUa
from Tumblr http://bit.ly/2HORiQ8
No comments:
Post a Comment